Vanda Pharmaceuticals Inc. financial data

Symbol
VNDA on Nasdaq
Location
Washington, DC
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 12 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 311% % -33%
Quick Ratio 1.6% % -2.6%
Debt-to-equity 31% % 53%
Return On Equity -49% % -1311%
Return On Assets -38% % -1195%
Operating Margin -70% % -242%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 59,108,030 shares 1.4%
Common Stock, Shares, Outstanding 59,101,630 shares 1.4%
Entity Public Float $268,700,000 USD -16%
Common Stock, Value, Issued $59,000 USD 1.7%
Weighted Average Number of Shares Outstanding, Basic 58,930,157 shares 1.3%
Weighted Average Number of Shares Outstanding, Diluted 58,930,157 shares 1.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $216,105,000 USD 8.7%
Revenue from Contract with Customer, Excluding Assessed Tax $216,105,000 USD 8.7%
Research and Development Expense $109,271,000 USD 47%
Costs and Expenses $367,273,000 USD 53%
Operating Income (Loss) $151,168,000 USD -272%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $138,647,000 USD -505%
Income Tax Expense (Benefit) $81,827,000 USD
Net Income (Loss) Attributable to Parent $220,474,000 USD -1067%
Earnings Per Share, Basic -3.74 USD/shares -1033%
Earnings Per Share, Diluted -3.74 USD/shares -1033%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $84,851,000 USD -17%
Accounts Receivable, after Allowance for Credit Loss, Current $54,578,000 USD 16%
Inventory, Net $1,852,000 USD 7.3%
Assets, Current $347,262,000 USD -21%
Deferred Income Tax Assets, Net $0 USD -100%
Property, Plant and Equipment, Net $2,248,000 USD 5.4%
Operating Lease, Right-of-Use Asset $3,923,000 USD -30%
Assets $488,948,000 USD -25%
Employee-related Liabilities, Current $10,322,000 USD 22%
Liabilities, Current $145,162,000 USD 45%
Operating Lease, Liability, Noncurrent $2,991,000 USD -40%
Other Liabilities, Noncurrent $9,533,000 USD -0.56%
Liabilities $161,762,000 USD 37%
Accumulated Other Comprehensive Income (Loss), Net of Tax $629,000 USD 750%
Retained Earnings (Accumulated Deficit) $394,766,000 USD -126%
Stockholders' Equity Attributable to Parent $327,186,000 USD -39%
Liabilities and Equity $488,948,000 USD -25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $33,147,000 USD -538%
Net Cash Provided by (Used in) Financing Activities $1,324,000 USD
Net Cash Provided by (Used in) Investing Activities $43,902,000 USD
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 59,101,630 shares 1.4%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $9,480,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $85,320,000 USD -17%
Deferred Tax Assets, Valuation Allowance $124,401,000 USD 1300%
Deferred Tax Assets, Gross $127,254,000 USD 38%
Operating Lease, Liability $5,143,000 USD -30%
Depreciation $231,000 USD 12%
Payments to Acquire Property, Plant, and Equipment $436,000 USD 6129%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $219,919,000 USD -1070%
Lessee, Operating Lease, Liability, to be Paid $5,670,000 USD -33%
Property, Plant and Equipment, Gross $14,864,000 USD 8.5%
Operating Lease, Liability, Current $2,152,000 USD -12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,159,000 USD -10%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,412,000 USD -14%
Operating Lease, Weighted Average Discount Rate, Percent 0.082 pure 0%
Deferred Income Tax Expense (Benefit) $7,797,000 USD -3070%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $527,000 USD -50%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,099,000 USD -49%
Deferred Tax Assets, Operating Loss Carryforwards $22,000,000 USD 269%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $19,575,000 USD 4.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,099,000 USD -49%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $7,007,000 USD -3.7%
Deferred Tax Assets, Net of Valuation Allowance $0 USD -100%
Share-based Payment Arrangement, Expense $9,474,000 USD -24%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%